Tatva Chintan Pharma Chem Ltd (TATVA)


📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 1026.00
% Change: 3.86% (Prev Close: 987.90)

Volume: 67,202
% Change: 14.78% (Prev Volume: 58,548)

Delivery: 19,429
Delivery % : 28.91
% Change: -24.50% (Prev Delivery: 25,735)

Turnover: 682 Lacs
% Change: 17.41% (Prev Turnover: 580)

💹 EOD Valuation

P/E Ratio: 335.29
P/B Ratio: 3.25
Market Cap: 2401 Rs. Cr.



Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: TATVA
Market Cap: 2433 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 1232.75
52 Week Low: 610.00

All-Time High: 2977.80 Rs.
All-Time Low: 610.00 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-5.82% | 14.86% | 50.78% | 8.91% | -24.27%


👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 72.02%

Change (3Y | 1Y): -7.15% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 3.26%

Change (3Y | 1Y): -0.27% | -0.04%

DII Holding

DII Holding: 5.11%

Change (3Y | 1Y): -5.64% | -0.35%

Public Holding: 19.60%


🏦 Financial Strength

Debt to Equity: 0.05
Debt: 36.39 Rs. Cr.

Book Value: 315.84 Rs.
Current Ratio: 2.76
Interest Coverage: 8.11
Free Cash Flow: -51.46 Rs. Cr.


📈 Growth & Sales

Sales Growth: 2.47%

Sales Growth Qtr (YOY | QoQ):
10.81% | 8.34%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
7.77% | -4.08% | 2.47%


💰 Profit & Earnings

Profit Growth %

Profit Growth: -72.52%

Profit Growth Qtr (YOY | QoQ):
27.64% | 545.63%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-31.41% | -60.88% | -72.52%


EPS Rs.

EPS (TTM): 3.06 Rs.

EPS Qtr (Last Year | Latest):
2.23 Rs. | 2.84 Rs.

EPS Annual (Last Annual | Annual March):
12.97 Rs. | 2.44 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-44.61% | -61.58%


Net Profit Rs. Cr.

Net Profit (TTM): 7.16 Rs. Cr.

Net Profit (Annual - March): 5.71 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
5.21| 1.03 | 6.65


EBITDA Rs. Cr.

EBITDA (Quarter): 18.48 Rs. Cr.
EBITDA (Previous Yr Ql): 13.78 Rs. Cr.

EBITDA (Annual - March): 36.79 Rs. Cr.
EBITDA (Previous Annual): 76.01 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
-8.28% | -32.09%


📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 9.88%

OPM Qtr (Previous | Current):
8.31% | 14.82%

OPM Annual (5 Yrs | Last Yr | March):
17.54% | 17.42% | 9.03%


Return on Equity %

ROE: 0.78%

ROE (5 Yrs | 3 Yrs | Last Yr):
10.05% | 4.57% | 4.86%


Return on Capital Employed %

ROCE: 1.20%

ROCE (5 Yrs | 3 Yrs | Last Yr):
14.18% | 5.71% | 7.02%


Return on Assets %

ROA (TTM): 0.69%

ROA (5 Yrs | 3 Yrs | Last Yr):
9.94% | 3.81% | 3.86%



PEG Ratio: -5.58
Dividend Yield: 0.10%

PE 3 Yrs: 76.73
PE 5 Yrs: 76.75

Dividend Yield: 0.10%


👥 Company

Tatva Chintan Pharma Chem Ltd

TATVA

Promoter Holding: %